Are there any new FDA-approved medications specifically targeting PCOS weight gain that do not cause severe gastrointestinal side effects for busy professionals?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Are there any new FDA-approved medications specifically targeting PCOS weight gain that do not cause severe gastrointestinal side effects for busy professionals?
3 real searches · 1 real-search pass
2026 FDA approved medications PCOS weight gain specifically approved PCOS obesity medications FDA labelGoogle ↗
OBSERVED
2023 international evidence-based guideline PCOS anti-obesity medications GLP-1 receptor agonists gastrointestinal adverse effectsGoogle ↗
OBSERVED
FDA obesity medications approved adults chronic weight management phentermine topiramate naltrexone bupropion orlistat semaglutide tirzepatide 2026Google ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
2026 FDA approved medications PCOS weight gain specifically approved PCOS obesity medications FDA label Google ↗
2023 international evidence-based guideline PCOS anti-obesity medications GLP-1 receptor agonists gastrointestinal adverse effects Google ↗
FDA obesity medications approved adults chronic weight management phentermine topiramate naltrexone bupropion orlistat semaglutide tirzepatide 2026 Google ↗
- Prescription Medications to Treat Overweight & Obesity · niddk.nih.gov
- FDA Approves New Medication for Chronic Weight Management · fda.gov
- FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutide · fda.gov
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polyendocrine Metabolic Ovarian Syndrome (2023) | American Society for Reproductive Medicine · prod.asrm.org
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2026 FDA approved medications PCOS weight gain specifically approved PCOS obesity medications FDA label OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
2023 international evidence-based guideline PCOS anti-obesity medications GLP-1 receptor agonists gastrointestinal adverse effects OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA obesity medications approved adults chronic weight management phentermine topiramate naltrexone bupropion orlistat semaglutide tirzepatide 2026 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |